HSS/Zimmer Biomet Innovation Center for AI in robotic joint replacement

Zimmer Biomet Holdings Inc. (ZB) and Hospital for Special Surgery (HSS) announced a three-year agreement to create the HSS/Zimmer Biomet (ZB) Innovation Center for Artificial Intelligence (AI) in robotic joint replacement. The companies aim to develop decision support tools, powered by data collection and machine learning, to provide data-driven recommendations to surgeons for robotic-assisted joint surgery.

"Forging a multi-year collaboration with a leading orthopedics institution combines HSS' clinical expertise with Zimmer Biomet's expertise in surgical robotics and AI modeling," said Ivan Tornos, chief operating officer at ZB. "This agreement, which is our second collaboration with HSS in two years, advances our vision to accelerate impactful innovation through strategic third-party relationships."

The decision support tools, will be integrated into the ROSA Knee and ROSA Hip systems to expand the capabilities of ZB's ZBEdge suite of smart, digital, and robotic technologies designed to deliver data-powered clinical insights with the goal of improving patient outcomes.

Over the course of the collaboration, a team of HSS surgeons and ZB data scientists will work to develop and test hypotheses that use data-driven insights to address clinical challenges associated with joint replacement surgery with the goal of using the validated hypotheses to inform the development of algorithms for the decision support tools.

"Through this unique collaboration, HSS can apply knowledge and expertise to transform musculoskeletal care with innovative technologies that can improve clinical outcomes, patient experience and cost efficiency in a meaningful way," said Louis A. Shapiro, president and CEO at HSS.